AROMASIN

This brand name is authorized in Austria, Australia, Brazil, Canada, Germany, Ecuador, Estonia, Finland, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Nigeria, Netherlands, New Zealand, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug AROMASIN contains one active pharmaceutical ingredient (API):

1 Exemestane UNII NY22HMQ4BX - EXEMESTANE

Exemestane is an irreversible, steroidal aromatase inhibitor, structurally related to the natural substrate androstenedione. Read about Exemestane

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
AROMASIN Coated tablets	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L02BG06	Exemestane	L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02B Hormone antagonists and related agents → L02BG Aromatase inhibitors
Discover more medicines within L02BG06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10103R, 8506Q
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 522718030074417
Country: CA	Health Products and Food Branch	Identifier(s): 02242705
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00361689, 00706384, 00706409, 07639343, 07639366, 09000817, 09155046, 10941910
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 30067-12-11
Country: EE	Ravimiamet	Identifier(s): 1011148
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 161547
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 26698, 299778, 373745
Country: HK	Department of Health Drug Office	Identifier(s): 46969
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-093797365
Country: IE	Health Products Regulatory Authority	Identifier(s): 13710, 13712, 13726, 62894
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4011
Country: IT	Agenzia del Farmaco	Identifier(s): 034678033, 045700010
Country: JP	医薬品医療機器総合機構	Identifier(s): 4291012F1022
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004069
Country: MT	Medicines Authority	Identifier(s): MA505/02801
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 185M2000
Country: NG	Registered Drug Product Database	Identifier(s): 04-9994
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 54917
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 9445
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65092001
Country: SG	Health Sciences Authority	Identifier(s): 11398P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681308121004
Country: US	FDA, National Drug Code	Identifier(s): 0009-7663
Country: ZA	Health Products Regulatory Authority	Identifier(s): 35/21.12/0011